Multi-target inhibitors in non-small cell lung cancer (NSCLC)

Ann Oncol. 2006 Mar;17 Suppl 2:ii55-57. doi: 10.1093/annonc/mdj924.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols*
  • Benzenesulfonates / administration & dosage
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • ErbB Receptors / antagonists & inhibitors
  • Humans
  • Indoles / administration & dosage
  • Lung Neoplasms / drug therapy*
  • Medical Oncology
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Piperidines / administration & dosage
  • Protein Kinase Inhibitors / administration & dosage
  • Pyridines / administration & dosage
  • Pyrroles / administration & dosage
  • Quinazolines / administration & dosage
  • Sorafenib
  • Sunitinib

Substances

  • Angiogenesis Inhibitors
  • Benzenesulfonates
  • Indoles
  • Phenylurea Compounds
  • Piperidines
  • Protein Kinase Inhibitors
  • Pyridines
  • Pyrroles
  • Quinazolines
  • Niacinamide
  • Sorafenib
  • ErbB Receptors
  • Sunitinib
  • vandetanib